首页> 外文期刊>Regulatory Affairs Journal- Devices >User fee negotiations in US offer hope for improvements to interactive review for medical device submissions
【24h】

User fee negotiations in US offer hope for improvements to interactive review for medical device submissions

机译:美国的使用费谈判为改善医疗设备提交的交互式审核提供了希望

获取原文
获取原文并翻译 | 示例
           

摘要

The US Food and Drug Administration's interactive review programme for medical device marketing applications is a critical process aimed at ensuring that companies are able to understand and meet the agency's expectations and bring their products to market in a timely fashion. The programme was formalised in the Medical Device User Fee Amendments of 2007 (MDUFA) as part of the reauthorisation of the Medical Device User Fee and Modernization Act (MDUFMA) of 2002, following successful negotiations by the medtech industry. Its creation was intended to improve interactions between FDA reviewers and companies during a product review, both to resolve minor issues informally and to alert the applicant to major issues identified by the FDA in advance of the agency issuing a formal letter
机译:美国食品和药物管理局针对医疗器械营销应用程序的交互式审核程序是一个关键过程,旨在确保公司能够理解并满足该机构的期望,并及时将其产品推向市场。在经过医疗技术行业的成功谈判之后,该计划在2007年的《医疗设备用户费用修正案》(MDUFA)中得到了正式批准,这是对2002年《医疗设备用户费用和现代化法案》(MDUFMA)进行重新授权的一部分。它的创建旨在改善产品审查过程中FDA审查人员与公司之间的互动,既可以非正式地解决小问题,也可以在机构发出正式信函之前提醒申请人注意FDA确定的主要问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号